Stay updated on Ligelizumab in CSU Adolescents & Adults Clinical Trial

Sign up to get notified when there's something new on the Ligelizumab in CSU Adolescents & Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ligelizumab in CSU Adolescents & Adults Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The record describes Novartis’s completed Phase III study of ligelizumab versus omalizumab and placebo for chronic spontaneous urticaria in adolescents and adults, with study design, eligibility, outcomes, and locations. It also includes results-related documents and information about sharing participant data.
    Difference
    100%
    Check dated 2026-11-10T22:44:06.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.2 to v3.8.0; the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T22:52:41.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A sitewide NIH notice was added about using “Super Intelligence” in place of “Artificial Intelligence” during a transition. The site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T21:56:55.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T22:12:56.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous study record content and navigation. This indicates restricted access to the page rather than a content update.
    Difference
    18%
    Check dated 2026-09-23T00:08:31.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    A new page revision tag was added (v3.7.0) and the previous revision (v3.6.6) was removed. This indicates a minor update to the page's documentation or rendering without changing the underlying study details.
    Difference
    0.0%
    Check dated 2026-09-15T23:59:27.000Z thumbnail image

Stay in the know with updates to Ligelizumab in CSU Adolescents & Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ligelizumab in CSU Adolescents & Adults Clinical Trial page.